Tokyo International Law Office

  • ABOUT
  • MEMBERS
  • PRACTICES
  • INFORMATION
  • RECRUIT
  • CONTACT
Language
  • 日本語
  • English

INSIGHT

  1. HOME
  2. INSIGHT
  • ALL
  • Healthcare, Life science
  • M&A
  • Cross-border Disputes (Litigation and Arbitration)
  • Corporate Governance
  • Regulatory
  • Construction/ Energy
  • TAX
  • Other

22.07.2026

【TKI Voice】How to Defend Against Activist Investors: A Practical Guide to Shareholder Proposals

How to Defend Against Activist Investors: A Practical Guide to Shareholder Proposals This page provides an En...

10.07.2026

【Client Alert】 Key Points under Japanese Law Regarding M&A of Medical Corporations

Key Points under Japanese Law Regarding M&A of Medical Corporations Key Questions (FAQ) ...

09.07.2026

【Client Alert】Telepharmacy: Regulatory Evolution and Current Framework

Telepharmacy: Regulatory Evolution and Current Framework This page provides an English executive summary of ...

08.07.2026

【Client Alert】Japan’s Antitrust Reform: Extending the “60-Day Payment Rule” to the Whole Supply Chain: Based on the JFTC Public Comments and Hearings on the Payment Notification

直近の動向を起点に、再生医療をめぐる制度の全体像と実務上の勘所をコンパクトに整理します。...

01.07.2026

【Client Alert】Dark Patterns in Japan: What Overseas Subscription Businesses Should Review Before Launching Campaigns, Trials, and Annual Plans entering or operating in Japan

In Japan, subscription risk should be reviewed across the entire customer journey - from the first price claim to cancel...

30.06.2026

【Client Alert】Japanese Advertising Regulations for Drugs, Medical Devices, Quasi-drugs and Cosmetics -Key points for overseas companies selling through online platforms in Japan

Japan is an important healthcare and beauty market, and many overseas companies now enter it through cross-border e-comm...

17.06.2026

【Client Alert】Entering Japan’s Online Health & Beauty Market: Advertising Compliance Risks for Platform Sellers

Entering Japan’s Online Health & Beauty Market: Advertising Compliance Risks for Platform Sellers This pa...

08.06.2026

【TKI Voice】Preparing for M&A and Investment: Regulatory Licenses in the Medical Device Business — Fundamentals and Structural Considerations

Preparing for M&A and Investment: Regulatory Licenses in the Medical Device Business — Fundamentals and Structu...

01.06.2026

【Client Alert】When Foreign Investment Goes Wrong: Investor-State Arbitration for Japanese Companies

Investor–State arbitration (often referred to as Investor–State Dispute Settlement, or ISDS) is a form of international ...

25.05.2026

【Client Alert】Documents-Only Arbitration: Fast, Fair, and Enforceable

This newsletter distills the discussion into a practical guide for parties weighing whether, and how, to take a dispute ...

22.05.2026

【TKI Voice】Cyberattack Countermeasures: Minimizing Damage Through Peacetime Preparation

【TKI Voice】Cyberattack Countermeasures: Minimizing Damage Through Peacetime Preparation Thi...

21.04.2026

【Client Alert】The Basic Regulatory Framework for Regenerative Medicine in Japan

The Basic Regulatory Framework for Regenerative Medicine in Japan This page provides an English ex...

  • 1
  • 2
  • …
  • 4
  • Next
  • ALL
  • Healthcare, Life science
  • M&A
  • Cross-border Disputes (Litigation and Arbitration)
  • Corporate Governance
  • Regulatory
  • Construction/ Energy
  • TAX
  • Other

  • ABOUT
  • MEMBERS
  • PRACTICES
  • INFORMATION
  • ACCESS
  • CONTACT

Tokyo International Law Office

P.O. BOX 571
ARK Mori Building 24F 1-12-32 Akasaka, Minato-ku
Tokyo 107-6024 Japan
TEL. +81(0)3-6843-2847

  • Privacy Policy for Europe
  • Privacy Policy for Japan

Copyright © Tokyo International Law Office All Rights Reserved.